DOI QR코드

DOI QR Code

Systematic Review of Available Guidelines on Fertility Preservation of Young Patients with Breast Cancer

  • Haddadi, Mahnaz (Cancer Models Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences) ;
  • Muhammadnejad, Samad (Research Center for Molecular and Cellular Imaging) ;
  • Sadeghi-Fazel, Fariba (Health Management Department, Quality Assurance Deputy, Razi Vaccine & Serum Research Institute) ;
  • Zandieh, Zahra (Anatomy Department, School of Medicine, Iran University of Medical Sciences) ;
  • Rahimi, Gohar (Research Group for Reproductive Medicine and IVF-Laboratory, Department of Obstetrics and Gynecology, Cologne University) ;
  • Sadighi, Sanambar (Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences) ;
  • Akbari, Parya (School of Medicine, Tehran University of Medical Sciences) ;
  • Mohagheghi, Mohammad-Ali (Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences) ;
  • Mosavi-Jarrahi, Alireza (Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences) ;
  • Amanpour, Saeid (Cancer Models Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences)
  • Published : 2015.03.04

Abstract

Background: Since the survival rate of breast cancer patients has improved, harmful effects of new treatment modalities on fertility of the young breast cancer patients has become a focus of attention. This study aimed to systematically review and critically appraise all available guidelines for fertility preservation in young breast cancer patients. Materials and Methods: Major citation databases were searched for treatment guidelines. Experts from relevant disciplines appraised the available guidelines. The AGREE II Instrument that includes 23 criteria in seven domains (scope and purpose of the guidelines, stakeholder involvement, rigor of development, clarity, applicability, editorial independence, and overall quality) was used to apprise and score the guidelines. Results: The search strategy retrieved 2,606 citations; 72 were considered for full-text screening and seven guidelines were included in the study. There was variability in the scores assigned to different domains among the guidelines. ASCO (2013), with an overall score of 68.0%, had the highest score, and St Gallen, with an overall score of 24.7%, had the lowest scores among the guidelines. Conclusions: With the promising survival rate among breast cancer patients, more attention should be given to include specific fertility preservation recommendations for young breast cancer patients.

Keywords

Fertility preservation;breast cancer;young women;practice guidelines

Acknowledgement

Supported by : Cancer Models Research Center, Tehran University of Medical Sciences

References

  1. AGREE Collaboration (2003). Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care, 12, 18-23. https://doi.org/10.1136/qhc.12.1.18
  2. Ajala T, Rafi J, Larsen-Disney P, et al (2010). Fertility preservation for cancer patients: a review. Obstet Gynecol Int, 2010, 160386.
  3. Bedoschi G, Turan V, Oktay K (2013). Utility of GnRH-agonists for fertility preservation in women with operable breast cancer: is it protective?. Curr Breast Cancer Rep, 5, 302-8. https://doi.org/10.1007/s12609-013-0123-y
  4. Bray F, Ren JS, Masuyer E, et al (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer, 132, 1133-45. https://doi.org/10.1002/ijc.27711
  5. Cardoso F1, Loibl S, Pagani O, et al (2012). The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer, 48, 3355-77. https://doi.org/10.1016/j.ejca.2012.10.004
  6. Christinat A, Pagani O (2012). Fertility after breast cancer. Maturitas, 73, 191-6. https://doi.org/10.1016/j.maturitas.2012.07.013
  7. Coccia PF, Altman J, Bhatia S, et al (2012). Adolescent and young adult oncology. JNCCN, 10, 1112-50.
  8. Cruz MR, Prestes JC, Gimenes DL, et al (2010). Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review. Fertil Steril, 94, 138-43. https://doi.org/10.1016/j.fertnstert.2009.02.055
  9. Demeestere I, Simon P, Emiliani S, et al (2007). Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist, 12, 1437-42. https://doi.org/10.1634/theoncologist.12-12-1437
  10. Dizon DS (2009). Quality of life after breast cancer: survivorship and sexuality. Breast J, 15, 500-4. https://doi.org/10.1111/j.1524-4741.2009.00766.x
  11. Dolmans MM, Jadoul P, Gilliaux S, et al (2013). A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet, 30, 305-14. https://doi.org/10.1007/s10815-013-9952-x
  12. Ethics Committee of the American Society for Reproductive Medicine (2005). Fertility preservation and reproduction in cancer patients. Fertil Steril, 83, 1622-8. https://doi.org/10.1016/j.fertnstert.2005.03.013
  13. Ewertz M, Jensen AB (2010). Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol, 50, 187-93.
  14. Fields E, Chard J, James D, et al (2013). Fertility [update]: summary of NICE guidance. BMJ, 20, 346-650.
  15. Forman EJ, Anders CK, Behera MA (2010). A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril, 94, 1652-6. https://doi.org/10.1016/j.fertnstert.2009.10.008
  16. Goldhirsch A, Ingle JN, Gelber RD, et al (2009). Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol, 20, 1319-29. https://doi.org/10.1093/annonc/mdp322
  17. Husseinzadeh N (2013). Preservation of ovarian function in young women with gynecologic cancer desiring future pregnancy: a review. AJCR, 1, 25-37.
  18. Husseinzadeh N, Husseinzadeh HD (2013). Preservation of fertility in female cancer patients desiring future child bearing; what is available and what can be offered. World J Oncol, 4, 1-7. https://doi.org/10.5306/wjco.v4.i1.1
  19. Imhof M, Hofstetter G, Bergmeister lH, et al (2004). Cryopreservation of a whole ovary as a strategy for restoring ovarian function. J Assist Reprod Genet, 21, 459-65. https://doi.org/10.1007/s10815-004-8763-5
  20. Isachenko V, Isachenko E, Reinsberg J ,et al (2007). Cryopreservation of human ovarian tissue: comparison of rapid and conventional freezing. Cryobiology, 55, 261-8. https://doi.org/10.1016/j.cryobiol.2007.08.008
  21. ISFP Practice Committee1, Kim SS, Donnez J, et al (2012). Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet, 29, 465-8. https://doi.org/10.1007/s10815-012-9786-y
  22. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  23. Jemal CK, Johnson R, Litton J, et al (2009). Breast cancer before age 40 years. Semin Oncol, 36, 237-49. https://doi.org/10.1053/j.seminoncol.2009.03.001
  24. Jeruss JS, Woodruff TK (2009). Preservation of fertility in patients with cancer. N Engl J Med, 360, 902-11. https://doi.org/10.1056/NEJMra0801454
  25. Keramatinia A, Mousavi-Jarrahi SH, Hiteh M, et al (2014). Trends in incidence of breast cancer among women under 40 in Asia. Asian Pac J Cancer Prev, 15, 1387-90. https://doi.org/10.7314/APJCP.2014.15.3.1387
  26. Kim SS, Klemp J, Fabian C (2011). Breast cancer and fertility preservation. Fertil Steril, 95, 1535-43. https://doi.org/10.1016/j.fertnstert.2011.01.003
  27. King JW, Davies MC, Roche N, et al (2012). Fertility preservation in women undergoing treatment for breast cancer in the UK: a questionnaire study. Oncologist, 17, 910-16. https://doi.org/10.1634/theoncologist.2012-0064
  28. Klemp JR, and Kim SS (2012). Fertility preservation in young women with breast cancer. J Assist Reprod Genet, 29, 469-72. https://doi.org/10.1007/s10815-012-9791-1
  29. Klock SC, Zhang JX, Kazer RR (2010). Fertility preservation for female cancer patients: early clinical experience. Fertil Steril, 94, 149-55. https://doi.org/10.1016/j.fertnstert.2009.03.028
  30. Lange S, Hurst BS, Matthews ML, et al (2013). Fertility preservation in patients with gynecologic cancer—part I: the impact of gynecologic malignancies on fertility. Postgraduate Obstet Gynecol, 33, 1-7.
  31. Lange S, Hurst BS, Matthews ML, et al (2013). Fertility preservation in patients with gynecologic cancer--part ii: current options and the ethics of oncofertility. Postgraduate Obstet Gynecol, 33, 1-5.
  32. Leclere B1, Molinie F, Tretarre B, et al (2013). Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol, 37, 544-9. https://doi.org/10.1016/j.canep.2013.05.001
  33. Leclere B1, Molinie F, Tretarre B, et al (2013). Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol, 37, 544-9. https://doi.org/10.1016/j.canep.2013.05.001
  34. Lobo RA (2005). Potential options for preservation of fertility in women. N Engl J Med, 353, 64-73. https://doi.org/10.1056/NEJMra043475
  35. Loren AW, Mangu PB, Beck LN, et al (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol, 31, 2500-10. https://doi.org/10.1200/JCO.2013.49.2678
  36. Maltaris T, Seufert R, Fischl F, et al (2007). The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol, 130, 148-55. https://doi.org/10.1016/j.ejogrb.2006.08.006
  37. Michaeli J, Weintraub M, Gross E, et al (2012). Fertility preservation in girls. Obstet Gynecol Int, 2012, 139193.
  38. National Collaborating Center for Women's and Children's Health (UK) (2004). Fertility: Assessment and Treatment for People with Fertility Problems. RCOG Press.
  39. Oktay K, Buyuk E, Davis O, et al (2003). Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod, 18, 90-5. https://doi.org/10.1093/humrep/deg045
  40. Oktay K, Buyuk E, Libertella N, et al (2005). Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol, 23, 4347-53. https://doi.org/10.1200/JCO.2005.05.037
  41. Partridge AH (2008). Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol, 26, 2612-13. https://doi.org/10.1200/JCO.2008.16.1976
  42. Peate M, Meiser B, Friedlander M, et al (2011). It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study. J Clin Oncol, 29, 1670-77. https://doi.org/10.1200/JCO.2010.31.2462
  43. Peccatori FA, Pup LD, Salvagno F, et al (2012). Fertility preservation methods in breast cancer. Breast Care, 7, 197-202. https://doi.org/10.1159/000339671
  44. Pentheroudakis G, Orecchia R, Hoekstra HJ, et al (2010). Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 266-73. https://doi.org/10.1093/annonc/mdq198
  45. Posada MN, Kolp L, García JE (2001). Fertility options for female cancer patients: facts and fiction. Fertil Steril, 75, 647-53. https://doi.org/10.1016/S0015-0282(00)01781-7
  46. Rahimi G, Isachenko V, Kreienberg R, et al (2010). Revascularisation in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. Eur J Obstet Gynecol Reprod Biol, 149, 63-7. https://doi.org/10.1016/j.ejogrb.2009.11.015
  47. Reinecke J (2013). On the frontlines of cancer & fertility: A Report on the 2013 ASRM Meeting. [www.asram.org]. LIVESTRONG.
  48. Rodriguez-Wallberg KA, Oktay K (2010). Fertility preservation in women with breast cancer. Clin Obstet Gynecol, 53, 753-62. https://doi.org/10.1097/GRF.0b013e3181f96e00
  49. Ronn R, and Holzer H (2013). Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol, 20, 465-74. https://doi.org/10.3747/co.20.1361
  50. Sonmezer M, Oktay K (2004). Fertility preservation in female patients. Hum Reprod Update, 10, 251-66. https://doi.org/10.1093/humupd/dmh021
  51. Sonmezer M, Oktay K (2006). Fertility preservation in young women undergoing breast cancer therapy. Oncologist, 11, 422-34.
  52. Theriault RL, Carlson RW, Allred C, et al (2013). Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw, 11, 753-60.
  53. Von Wolff M, Dittrich R, Denschlag D, et al (2011). Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet, 284, 427-35. https://doi.org/10.1007/s00404-011-1874-1
  54. Wallace WH, Anderson RA, Irvine DS (2005). Fertility preservation for young patients with cancer: who is at risk and what can be offered?. Lancet Oncol, 6, 209-18. https://doi.org/10.1016/S1470-2045(05)70092-9

Cited by

  1. Guideline appraisal with AGREE II: Systematic review of the current evidence on how users handle the 2 overall assessments vol.12, pp.3, 2017, https://doi.org/10.1371/journal.pone.0174831